🟢 Enhanced Group is trading 10.1% up in pre-market

Enhanced Group is trading 10.1% higher in pre-market at $7.83, with no verified company-specific announcement or reliable report explaining the move.

• This compares with the November 4 close of $7.11.
• Recent coverage included expanded clinician-led access to six peptides and a 60% reduction in shares scheduled for lock-up release. Those announcements were made November 2–3 and have not been tied to the gain.
• Pre-market trading activity data was unavailable.